Entry - #114000 - CAFFEY DISEASE; CAFYD - OMIM
# 114000

CAFFEY DISEASE; CAFYD


Alternative titles; symbols

INFANTILE CORTICAL HYPEROSTOSIS


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
17q21.33 Caffey disease 114000 AD 3 COL1A1 120150
Clinical Synopsis
 

Skel
- Hot, tender swelling of involved bones (e.g., mandible, ribs)
Limbs
- Mild congenital leg curvature
Misc
- Usually appears by 5 months of age
- Fever
- Specific bones involved different in familial and sporadic cases
Radiology
- Identified by x-ray in the fetus in utero
- Cortical hyperostosis
- Curved tibia
- Irregularity of bone cortex
Lab
- Thickened periosteum and infiltration of the deeper layers of the periosteum with round cells
Inheritance
- Autosomal dominant

TEXT

A number sign (#) is used with this entry because of evidence that Caffey disease (CAFYD) is caused by heterozygous mutation in the alpha-1 collagen type I gene (COL1A1; 120150) on chromosome 17q21.


Description

Caffey disease (CAFYD) is an autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. Painful swelling and systemic fever often accompany the episode, which usually begins before the age of 5 months and resolves before age 2 years. Laboratory findings include an elevated level of alkaline phosphatase and sometimes an elevation in white blood cell count and erythrocyte sedimentation rate. Recurrent episodes are uncommon (summary by Gensure et al., 2005).


Clinical Features

Caffey disease, also known as infantile cortical hyperostosis, has somewhat unusual features for a hereditary disorder. It rarely if ever appears after 5 months of age and usually resolves spontaneously by 2 years of age; it is sometimes present at birth and has been identified by x-ray in the fetus in utero. The acute manifestations are inflammatory in nature, with fever and hot, tender swelling of involved bones (e.g., mandible, ribs). Despite striking radiologic changes in the acute stages, previously affected bones are often completely normal on restudy. However, Taj-Eldin and Al-Jawad (1971) described a case followed since infancy with recurrences documented up to 19 years of age (1971). (Incontinentia pigmenti (308300) is another familial condition in which 'active' lesions at birth and early in life may leave little or no residue.) Pickering and Cuddigan (1969) suggested that vascular occlusion secondary to thrombocytosis may be involved in the pathogenesis. X-ray findings in 3 members of the family were reported by Pajewski and Vure (1967).

MacLachlan et al. (1984) followed up on the French-Canadian kindred reported by Gerrard et al. (1961). To the 14 affected children identified in the original report, 20 new cases were added. MacLachlan et al. (1984) commented that the sporadic form of the disorder is disappearing with no such cases seen in the last 7 years. In sporadic cases the bones most often affected are mandible, ulna, and clavicle with fairly frequent involvement of ribs and scapulae. In their radiographic studies of 14 familial cases, no involvement of ribs or scapulae was encountered. Clavicular involvement was found in only 3 children. The tibia was most often involved in familial cases. Borochowitz et al. (1991) described 2 affected sibs in a nonconsanguineous family; a girl had involvement of the fibula at the age of 5 months and a recurrence with tibial involvement at the age of 11 years. Her brother was hospitalized at the age of 4 months because of swelling of the face, fever, and restlessness.

Suphapeetiporn et al. (2007) reported a 3-generation Thai family in which 5 individuals had Caffey disease. The oldest individual, a 75-year-old man, had bowed legs since childhood, several traumatic fractures, short hands, kyphoscoliosis and compression fractures of the vertebrae. Examination of other affected family members showed angular deformities of the long bones, short stature, and dental caries, although unaffected family members also had dental caries. The authors suggested that short stature and persistent bony deformities should be included in the clinical spectrum of Caffey disease.

Clinical Variability

Lecolier et al. (1992) described a case of prenatal Caffey disease. Ultrasound examination at 20 weeks' gestation detected major angulation of the long bones. Although no fractures were seen, irregularities of the ribs suggested multiple callus formation and the diagnosis of lethal osteogenesis imperfecta was entertained. Cordocentesis showed marked leukocytosis, mainly due to neutrophils, as well as increased serum levels of hepatic enzymes. Because of a rapid appearance of 'fetoplacental anasarca' and a probable diagnosis of osteogenesis imperfecta, pregnancy was terminated at 23 weeks' gestation. Special x-ray views showed a double contour of the diaphyseal cortex of the long bones. Histologic examination confirmed the diagnosis of Caffey disease by demonstration of thickened periosteum and infiltration of the deeper layers of the periosteum with round cells. Lecolier et al. (1992) suggested that this form should be referred to as lethal prenatal cortical hyperostosis.

Perinatal death in 2 sibs with Caffey disease was described by de Jong and Muller (1995). Antenatal sonographic diagnosis was short-limb dwarfism and thoracic dysplasia of a nonspecific type, possibly osteogenesis imperfecta, in the first sib. The second sib had a similar appearance on ultrasonography. The thickened irregularly echodense diaphyses were an aid to diagnosis. De Jong and Muller (1995) agreed with LeColier et al. (1992) that fetoplacental anasarca and polyhydramnios are helpful prognostic signs. The presence of both seems to indicate a very poor prognosis. Autosomal dominant inheritance with subclinical Caffey disease in one of the parents during infancy could not be excluded since incidental discovery of the disease has been reported (Cayler and Peterson, 1956). Parental gonadal mosaicism is another possibility. In spite of the absence of parental consanguinity, the occurrence of the condition in a male and a female sib born to healthy parents suggested autosomal recessive inheritance of the lethal prenatal onset type of cortical hyperostosis.

Kamoun-Goldrat et al. (2008) described a fetus that represented the first pregnancy of a young, healthy, nonconsanguineous couple. The pregnancy was medically terminated at 30 weeks' gestation after a diagnosis of severe osteogenesis imperfecta. Postmortem radiographs, autopsy, and histologic study showed typical features of a severe form of prenatal cortical hyperostosis.


Diagnosis

Prenatal Diagnosis

Stevenson (1993) described a case indicating that Caffey disease can be detected in utero in familial nonlethal cases. Ultrasound examination at age 35.5 weeks showed curvature of the tibia and irregularity of the cortex of the radius. Mild leg curvature was present at birth at 39 weeks; involvement of all long bones was documented radiographically at the age of 2.5 months. A sister, the mother, and a maternal uncle had documented Caffey disease.


Inheritance

Autosomal dominant inheritance of Caffey disease is suggested by the reports of Gerrard et al. (1961), Van Buskirk et al. (1961), Holman (1962), and others. Male-to-male transmission was observed by Van Buskirk et al. (1961). Bull and Feingold (1974) reported 2 affected sisters, one of whom had affected son and daughter and the other a normal daughter and affected son. Fried et al. (1981) observed 9 affected persons in 3 sibships of 2 generations of a family. One instance of male-to-male transmission and one of apparent nonpenetrance were reported. Newberg and Tampas (1981) gave a follow-up on a family with 11 cases reported in 1961 (Tampas et al., 1961; Van Buskirk et al., 1961). Since then, 10 new cases had occurred, confirming autosomal dominant inheritance. Emmery et al. (1983) described 8 affected persons in 3 generations.

Of the 24 affected members of a family segregating Caffey disease in which Gensure et al. (2005) identified an R836C mutation in the COL1A1 gene (120150.0063), only 19 (79%) had experienced an episode of cortical hyperostosis and 5 (21%) obligate carriers had not, consistent with reduced penetrance.


Mapping

Gensure et al. (2005) performed genomewide mapping of a large family with Caffey disease, which revealed linkage to chromosome 17q21. Fine mapping reduced the linked region to a 2.3-Mb interval between markers D17S1868 and D17S1877; the maximum 2-point lod score obtained was 6.78 for marker D17S1795 (theta = 0.0).


Molecular Genetics

In affected individuals and obligate carriers from 3 unrelated families with Caffey disease, Gensure et al. (2005) identified heterozygosity for an arg836-to-cys mutation in the COL1A1 gene (R836C; 120150.0063), involving the triple-helical domain of the alpha-1 chain of type I collagen. None of the affected individuals or obligate carriers in any of the families had clinical signs of the major type I collagen disorder, osteogenesis imperfecta (see 166200); however, in 2 of the 3 families, individuals carrying the mutation did have joint hyperlaxity, hyperextensible skin, and inguinal hernias, features seen in Ehlers-Danlos syndrome (see 130000), some forms of which are caused by mutations in COL1A1.

In affected members of a Thai family with Caffey disease, Suphapeetiporn et al. (2007) identified heterozygosity for the R836C mutation in the COL1A1 gene.

Kamoun-Goldrat et al. (2008) identified heterozygosity for the R836C mutation in the COL1A1 gene in the pulmonary tissue of a fetus with a severe form of prenatal cortical hyperostosis from a terminated pregnancy at 30 weeks' gestation. They noted that this mutation had not been found in 2 other such cases by Gensure et al. (2005) and speculated that mutations in other genes were likely involved in the prenatal and infantile forms of cortical hyperostosis.

Associations Pending Confirmation

For a discussion of a possible association between Caffey disease and variation in the AHSG gene, see 138680.0005.


History

See Griscom (1995) for a biographic account of John Caffey (1895-1978).


REFERENCES

  1. Borochowitz, Z., Gozal, D., Misselevitch, I., Aunallah, J., Boss, J. H. Familial Caffey's disease and late recurrence in a child. Clin. Genet. 40: 329-335, 1991. [PubMed: 1756606, related citations] [Full Text]

  2. Bull, M. J., Feingold, M. Autosomal dominant inheritance of Caffey disease. Birth Defects Orig. Art. Ser. X: 139-146, 1974. [PubMed: 4609117, related citations]

  3. Caffey, J., Silverman, W. Infantile cortical hyperostosis, preliminary report on new syndrome. Am. J. Roentgen. 54: 1-16, 1945.

  4. Cayler, G. G., Peterson, C. A. Infantile cortical hyperostosis: report of seventeen cases. Am. J. Dis. Child. 91: 119-125, 1956. [PubMed: 13282620, related citations] [Full Text]

  5. Clemett, A. R., Williams, J. H. The familial occurrence of infantile cortical hyperostosis. Radiology 80: 409-416, 1963. [PubMed: 14021697, related citations] [Full Text]

  6. de Jong, G., Muller, L. M. M. Perinatal death in two sibs with infantile cortical hyperostosis (Caffey disease). Am. J. Med. Genet. 59: 134-138, 1995. [PubMed: 8588573, related citations] [Full Text]

  7. Emmery, L., Timmermans, J., Christens, J., Fryns, J. P. Familial infantile cortical hyperostosis. Europ. J. Pediat. 141: 56-58, 1983. [PubMed: 6357801, related citations] [Full Text]

  8. Fried, K., Manor, A., Pajewski, M., Starinsky, R., Vure, E. Autosomal dominant inheritance with incomplete penetrance of Caffey disease (infantile cortical hyperostosis). Clin. Genet. 19: 271-274, 1981. [PubMed: 7023758, related citations] [Full Text]

  9. Gensure, R. C., Makitie, O., Barclay, C., Chan, C., DePalma, S. R., Bastepe, M., Abuzahra, H., Couper, R., Mundlos, S., Sillence, D., Ala Kokko, L., Seidman, J. G., Cole, W. G., Juppner, H. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J. Clin. Invest. 115: 1250-1257, 2005. [PubMed: 15864348, images, related citations] [Full Text]

  10. Gerrard, J. W., Holman, G. H., Gorman, A. A., Morrow, I. H. Familial infantile cortical hyperostosis. J. Pediat. 59: 543-548, 1961. [PubMed: 13898040, related citations] [Full Text]

  11. Griscom, N. T. John Caffey and his contributions to radiology. Radiology 194: 513-518, 1995. [PubMed: 7824734, related citations] [Full Text]

  12. Holman, G. H. Infantile cortical hyperostosis: a review. Quart. Rev. Pediat. 17: 24-31, 1962. [PubMed: 13908496, related citations]

  13. Kamoun-Goldrat, A., Martinovic, J., Saada, J., Sonigo-Cohen, P., Razavi, F., Munnich, A., Le Merrer, M. Prenatal cortical hyperostosis with COL1A1 gene mutation. Am. J. Med. Genet. 146A: 1820-1824, 2008. [PubMed: 18553566, related citations] [Full Text]

  14. Langewisch, W. H. Infantile cortical hyperostosis--familial occurrence in a mother and daughter. J. Pediat. 87: 323-324, 1975. [PubMed: 1097622, related citations] [Full Text]

  15. Lecolier, B., Bercau, G., Gonzales, M., Afriat, R., Rambaud, D., Mulliez, N., de Kermadec, S. Radiographic, haematological, and biochemical findings in a fetus with Caffey disease. Prenatal Diag. 12: 637-641, 1992. [PubMed: 1359527, related citations] [Full Text]

  16. MacLachlan, A. K., Gerrard, J. W., Houston, C. S., Ives, E. J. Familial infantile cortical hyperostosis in a large Canadian family. Canad. Med. Assoc. J. 130: 1172-1174, 1984. [PubMed: 6370402, related citations]

  17. Newberg, A. H., Tampas, J. P. Familial infantile cortical hyperostosis: an update. Am. J. Roentgen. 137: 93-96, 1981. [PubMed: 6787897, related citations] [Full Text]

  18. Pajewski, M., Vure, E. Late manifestations of infantile cortical hyperostosis (Caffey's disease). Brit. J. Radiol. 40: 90-95, 1967. [PubMed: 5334797, related citations] [Full Text]

  19. Pickering, D., Cuddigan, B. Infantile cortical hyperostosis associated with thrombocythaemia. Lancet 294: 464-465, 1969. Note: Originally Volume II. [PubMed: 4183907, related citations] [Full Text]

  20. Sherman, M. S., Hellyer, D. T. Infantile cortical hyperostosis: review of the literature and report of 5 cases. Am. J. Roentgen. 63: 212-222, 1950.

  21. Sidbury, J. B., Jr. Infantile cortical hyperostosis. Postgrad. Med. 22: 211-215, 1957. [PubMed: 13465549, related citations] [Full Text]

  22. Stevenson, R. E. Findings of heritable Caffey disease on ultrasound at 35 1/2 weeks gestation. Proc. Greenwood Genet. Center 12: 16-18, 1993.

  23. Suphapeetiporn, K., Tongkobpetch, S., Mahayosnond, A., Shotelersuk, V. Expanding the phenotypic spectrum of Caffey disease. Clin. Genet. 71: 280-284, 2007. [PubMed: 17309652, related citations] [Full Text]

  24. Taj-Eldin, S., Al-Jawad, J. Cortical hyperostosis: infantile and juvenile manifestations in a boy. Arch. Dis. Child. 46: 565-566, 1971. [PubMed: 4935623, related citations] [Full Text]

  25. Tampas, J. P., Van Buskirk, F. W., Peterson, O. S., Soule, A. B. Infantile cortical hyperostosis. JAMA 175: 491-493, 1961. [PubMed: 13775121, related citations] [Full Text]

  26. Van Buskirk, F. W., Tampas, J. P., Peterson, O. S., Jr. Infantile cortical hyperostosis: an inquiry into its familial aspects. Am. J. Roentgen. Radium Ther. Nucl. Med. 85: 613-632, 1961. [PubMed: 13779881, related citations]


Nara Sobreira - updated : 6/17/2009
Cassandra L. Kniffin - updated : 8/29/2007
Marla J. F. O'Neill - updated : 5/20/2005
Creation Date:
Victor A. McKusick : 6/4/1986
carol : 01/03/2024
carol : 01/02/2024
alopez : 02/15/2022
carol : 01/28/2020
carol : 01/21/2015
carol : 4/5/2012
carol : 6/18/2009
terry : 6/17/2009
terry : 6/3/2009
terry : 1/8/2009
wwang : 9/10/2007
ckniffin : 8/29/2007
carol : 6/23/2005
carol : 6/23/2005
carol : 5/25/2005
wwang : 5/23/2005
terry : 5/20/2005
alopez : 3/17/2004
alopez : 4/8/1999
alopez : 7/9/1997
terry : 3/26/1996
mark : 1/16/1996
terry : 1/11/1996
carol : 3/7/1995
davew : 6/9/1994
terry : 5/13/1994
mimadm : 4/9/1994
warfield : 4/6/1994
carol : 10/26/1993

# 114000

CAFFEY DISEASE; CAFYD


Alternative titles; symbols

INFANTILE CORTICAL HYPEROSTOSIS


SNOMEDCT: 24752008;   ICD10CM: M89.8;   ORPHA: 1310;   DO: 4257;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
17q21.33 Caffey disease 114000 Autosomal dominant 3 COL1A1 120150

TEXT

A number sign (#) is used with this entry because of evidence that Caffey disease (CAFYD) is caused by heterozygous mutation in the alpha-1 collagen type I gene (COL1A1; 120150) on chromosome 17q21.


Description

Caffey disease (CAFYD) is an autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. Painful swelling and systemic fever often accompany the episode, which usually begins before the age of 5 months and resolves before age 2 years. Laboratory findings include an elevated level of alkaline phosphatase and sometimes an elevation in white blood cell count and erythrocyte sedimentation rate. Recurrent episodes are uncommon (summary by Gensure et al., 2005).


Clinical Features

Caffey disease, also known as infantile cortical hyperostosis, has somewhat unusual features for a hereditary disorder. It rarely if ever appears after 5 months of age and usually resolves spontaneously by 2 years of age; it is sometimes present at birth and has been identified by x-ray in the fetus in utero. The acute manifestations are inflammatory in nature, with fever and hot, tender swelling of involved bones (e.g., mandible, ribs). Despite striking radiologic changes in the acute stages, previously affected bones are often completely normal on restudy. However, Taj-Eldin and Al-Jawad (1971) described a case followed since infancy with recurrences documented up to 19 years of age (1971). (Incontinentia pigmenti (308300) is another familial condition in which 'active' lesions at birth and early in life may leave little or no residue.) Pickering and Cuddigan (1969) suggested that vascular occlusion secondary to thrombocytosis may be involved in the pathogenesis. X-ray findings in 3 members of the family were reported by Pajewski and Vure (1967).

MacLachlan et al. (1984) followed up on the French-Canadian kindred reported by Gerrard et al. (1961). To the 14 affected children identified in the original report, 20 new cases were added. MacLachlan et al. (1984) commented that the sporadic form of the disorder is disappearing with no such cases seen in the last 7 years. In sporadic cases the bones most often affected are mandible, ulna, and clavicle with fairly frequent involvement of ribs and scapulae. In their radiographic studies of 14 familial cases, no involvement of ribs or scapulae was encountered. Clavicular involvement was found in only 3 children. The tibia was most often involved in familial cases. Borochowitz et al. (1991) described 2 affected sibs in a nonconsanguineous family; a girl had involvement of the fibula at the age of 5 months and a recurrence with tibial involvement at the age of 11 years. Her brother was hospitalized at the age of 4 months because of swelling of the face, fever, and restlessness.

Suphapeetiporn et al. (2007) reported a 3-generation Thai family in which 5 individuals had Caffey disease. The oldest individual, a 75-year-old man, had bowed legs since childhood, several traumatic fractures, short hands, kyphoscoliosis and compression fractures of the vertebrae. Examination of other affected family members showed angular deformities of the long bones, short stature, and dental caries, although unaffected family members also had dental caries. The authors suggested that short stature and persistent bony deformities should be included in the clinical spectrum of Caffey disease.

Clinical Variability

Lecolier et al. (1992) described a case of prenatal Caffey disease. Ultrasound examination at 20 weeks' gestation detected major angulation of the long bones. Although no fractures were seen, irregularities of the ribs suggested multiple callus formation and the diagnosis of lethal osteogenesis imperfecta was entertained. Cordocentesis showed marked leukocytosis, mainly due to neutrophils, as well as increased serum levels of hepatic enzymes. Because of a rapid appearance of 'fetoplacental anasarca' and a probable diagnosis of osteogenesis imperfecta, pregnancy was terminated at 23 weeks' gestation. Special x-ray views showed a double contour of the diaphyseal cortex of the long bones. Histologic examination confirmed the diagnosis of Caffey disease by demonstration of thickened periosteum and infiltration of the deeper layers of the periosteum with round cells. Lecolier et al. (1992) suggested that this form should be referred to as lethal prenatal cortical hyperostosis.

Perinatal death in 2 sibs with Caffey disease was described by de Jong and Muller (1995). Antenatal sonographic diagnosis was short-limb dwarfism and thoracic dysplasia of a nonspecific type, possibly osteogenesis imperfecta, in the first sib. The second sib had a similar appearance on ultrasonography. The thickened irregularly echodense diaphyses were an aid to diagnosis. De Jong and Muller (1995) agreed with LeColier et al. (1992) that fetoplacental anasarca and polyhydramnios are helpful prognostic signs. The presence of both seems to indicate a very poor prognosis. Autosomal dominant inheritance with subclinical Caffey disease in one of the parents during infancy could not be excluded since incidental discovery of the disease has been reported (Cayler and Peterson, 1956). Parental gonadal mosaicism is another possibility. In spite of the absence of parental consanguinity, the occurrence of the condition in a male and a female sib born to healthy parents suggested autosomal recessive inheritance of the lethal prenatal onset type of cortical hyperostosis.

Kamoun-Goldrat et al. (2008) described a fetus that represented the first pregnancy of a young, healthy, nonconsanguineous couple. The pregnancy was medically terminated at 30 weeks' gestation after a diagnosis of severe osteogenesis imperfecta. Postmortem radiographs, autopsy, and histologic study showed typical features of a severe form of prenatal cortical hyperostosis.


Diagnosis

Prenatal Diagnosis

Stevenson (1993) described a case indicating that Caffey disease can be detected in utero in familial nonlethal cases. Ultrasound examination at age 35.5 weeks showed curvature of the tibia and irregularity of the cortex of the radius. Mild leg curvature was present at birth at 39 weeks; involvement of all long bones was documented radiographically at the age of 2.5 months. A sister, the mother, and a maternal uncle had documented Caffey disease.


Inheritance

Autosomal dominant inheritance of Caffey disease is suggested by the reports of Gerrard et al. (1961), Van Buskirk et al. (1961), Holman (1962), and others. Male-to-male transmission was observed by Van Buskirk et al. (1961). Bull and Feingold (1974) reported 2 affected sisters, one of whom had affected son and daughter and the other a normal daughter and affected son. Fried et al. (1981) observed 9 affected persons in 3 sibships of 2 generations of a family. One instance of male-to-male transmission and one of apparent nonpenetrance were reported. Newberg and Tampas (1981) gave a follow-up on a family with 11 cases reported in 1961 (Tampas et al., 1961; Van Buskirk et al., 1961). Since then, 10 new cases had occurred, confirming autosomal dominant inheritance. Emmery et al. (1983) described 8 affected persons in 3 generations.

Of the 24 affected members of a family segregating Caffey disease in which Gensure et al. (2005) identified an R836C mutation in the COL1A1 gene (120150.0063), only 19 (79%) had experienced an episode of cortical hyperostosis and 5 (21%) obligate carriers had not, consistent with reduced penetrance.


Mapping

Gensure et al. (2005) performed genomewide mapping of a large family with Caffey disease, which revealed linkage to chromosome 17q21. Fine mapping reduced the linked region to a 2.3-Mb interval between markers D17S1868 and D17S1877; the maximum 2-point lod score obtained was 6.78 for marker D17S1795 (theta = 0.0).


Molecular Genetics

In affected individuals and obligate carriers from 3 unrelated families with Caffey disease, Gensure et al. (2005) identified heterozygosity for an arg836-to-cys mutation in the COL1A1 gene (R836C; 120150.0063), involving the triple-helical domain of the alpha-1 chain of type I collagen. None of the affected individuals or obligate carriers in any of the families had clinical signs of the major type I collagen disorder, osteogenesis imperfecta (see 166200); however, in 2 of the 3 families, individuals carrying the mutation did have joint hyperlaxity, hyperextensible skin, and inguinal hernias, features seen in Ehlers-Danlos syndrome (see 130000), some forms of which are caused by mutations in COL1A1.

In affected members of a Thai family with Caffey disease, Suphapeetiporn et al. (2007) identified heterozygosity for the R836C mutation in the COL1A1 gene.

Kamoun-Goldrat et al. (2008) identified heterozygosity for the R836C mutation in the COL1A1 gene in the pulmonary tissue of a fetus with a severe form of prenatal cortical hyperostosis from a terminated pregnancy at 30 weeks' gestation. They noted that this mutation had not been found in 2 other such cases by Gensure et al. (2005) and speculated that mutations in other genes were likely involved in the prenatal and infantile forms of cortical hyperostosis.

Associations Pending Confirmation

For a discussion of a possible association between Caffey disease and variation in the AHSG gene, see 138680.0005.


History

See Griscom (1995) for a biographic account of John Caffey (1895-1978).


See Also:

Caffey and Silverman (1945); Clemett and Williams (1963); Langewisch (1975); Sherman and Hellyer (1950); Sidbury (1957)

REFERENCES

  1. Borochowitz, Z., Gozal, D., Misselevitch, I., Aunallah, J., Boss, J. H. Familial Caffey's disease and late recurrence in a child. Clin. Genet. 40: 329-335, 1991. [PubMed: 1756606] [Full Text: https://doi.org/10.1111/j.1399-0004.1991.tb03104.x]

  2. Bull, M. J., Feingold, M. Autosomal dominant inheritance of Caffey disease. Birth Defects Orig. Art. Ser. X: 139-146, 1974. [PubMed: 4609117]

  3. Caffey, J., Silverman, W. Infantile cortical hyperostosis, preliminary report on new syndrome. Am. J. Roentgen. 54: 1-16, 1945.

  4. Cayler, G. G., Peterson, C. A. Infantile cortical hyperostosis: report of seventeen cases. Am. J. Dis. Child. 91: 119-125, 1956. [PubMed: 13282620] [Full Text: https://doi.org/10.1001/archpedi.1956.02060020121003]

  5. Clemett, A. R., Williams, J. H. The familial occurrence of infantile cortical hyperostosis. Radiology 80: 409-416, 1963. [PubMed: 14021697] [Full Text: https://doi.org/10.1148/80.3.409]

  6. de Jong, G., Muller, L. M. M. Perinatal death in two sibs with infantile cortical hyperostosis (Caffey disease). Am. J. Med. Genet. 59: 134-138, 1995. [PubMed: 8588573] [Full Text: https://doi.org/10.1002/ajmg.1320590203]

  7. Emmery, L., Timmermans, J., Christens, J., Fryns, J. P. Familial infantile cortical hyperostosis. Europ. J. Pediat. 141: 56-58, 1983. [PubMed: 6357801] [Full Text: https://doi.org/10.1007/BF00445672]

  8. Fried, K., Manor, A., Pajewski, M., Starinsky, R., Vure, E. Autosomal dominant inheritance with incomplete penetrance of Caffey disease (infantile cortical hyperostosis). Clin. Genet. 19: 271-274, 1981. [PubMed: 7023758] [Full Text: https://doi.org/10.1111/j.1399-0004.1981.tb00708.x]

  9. Gensure, R. C., Makitie, O., Barclay, C., Chan, C., DePalma, S. R., Bastepe, M., Abuzahra, H., Couper, R., Mundlos, S., Sillence, D., Ala Kokko, L., Seidman, J. G., Cole, W. G., Juppner, H. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J. Clin. Invest. 115: 1250-1257, 2005. [PubMed: 15864348] [Full Text: https://doi.org/10.1172/JCI22760]

  10. Gerrard, J. W., Holman, G. H., Gorman, A. A., Morrow, I. H. Familial infantile cortical hyperostosis. J. Pediat. 59: 543-548, 1961. [PubMed: 13898040] [Full Text: https://doi.org/10.1016/s0022-3476(61)80238-2]

  11. Griscom, N. T. John Caffey and his contributions to radiology. Radiology 194: 513-518, 1995. [PubMed: 7824734] [Full Text: https://doi.org/10.1148/radiology.194.2.7824734]

  12. Holman, G. H. Infantile cortical hyperostosis: a review. Quart. Rev. Pediat. 17: 24-31, 1962. [PubMed: 13908496]

  13. Kamoun-Goldrat, A., Martinovic, J., Saada, J., Sonigo-Cohen, P., Razavi, F., Munnich, A., Le Merrer, M. Prenatal cortical hyperostosis with COL1A1 gene mutation. Am. J. Med. Genet. 146A: 1820-1824, 2008. [PubMed: 18553566] [Full Text: https://doi.org/10.1002/ajmg.a.32351]

  14. Langewisch, W. H. Infantile cortical hyperostosis--familial occurrence in a mother and daughter. J. Pediat. 87: 323-324, 1975. [PubMed: 1097622] [Full Text: https://doi.org/10.1016/s0022-3476(75)80612-3]

  15. Lecolier, B., Bercau, G., Gonzales, M., Afriat, R., Rambaud, D., Mulliez, N., de Kermadec, S. Radiographic, haematological, and biochemical findings in a fetus with Caffey disease. Prenatal Diag. 12: 637-641, 1992. [PubMed: 1359527] [Full Text: https://doi.org/10.1002/pd.1970120803]

  16. MacLachlan, A. K., Gerrard, J. W., Houston, C. S., Ives, E. J. Familial infantile cortical hyperostosis in a large Canadian family. Canad. Med. Assoc. J. 130: 1172-1174, 1984. [PubMed: 6370402]

  17. Newberg, A. H., Tampas, J. P. Familial infantile cortical hyperostosis: an update. Am. J. Roentgen. 137: 93-96, 1981. [PubMed: 6787897] [Full Text: https://doi.org/10.2214/ajr.137.1.93]

  18. Pajewski, M., Vure, E. Late manifestations of infantile cortical hyperostosis (Caffey's disease). Brit. J. Radiol. 40: 90-95, 1967. [PubMed: 5334797] [Full Text: https://doi.org/10.1259/0007-1285-40-470-90]

  19. Pickering, D., Cuddigan, B. Infantile cortical hyperostosis associated with thrombocythaemia. Lancet 294: 464-465, 1969. Note: Originally Volume II. [PubMed: 4183907] [Full Text: https://doi.org/10.1016/s0140-6736(69)90168-8]

  20. Sherman, M. S., Hellyer, D. T. Infantile cortical hyperostosis: review of the literature and report of 5 cases. Am. J. Roentgen. 63: 212-222, 1950.

  21. Sidbury, J. B., Jr. Infantile cortical hyperostosis. Postgrad. Med. 22: 211-215, 1957. [PubMed: 13465549] [Full Text: https://doi.org/10.1080/00325481.1957.11691897]

  22. Stevenson, R. E. Findings of heritable Caffey disease on ultrasound at 35 1/2 weeks gestation. Proc. Greenwood Genet. Center 12: 16-18, 1993.

  23. Suphapeetiporn, K., Tongkobpetch, S., Mahayosnond, A., Shotelersuk, V. Expanding the phenotypic spectrum of Caffey disease. Clin. Genet. 71: 280-284, 2007. [PubMed: 17309652] [Full Text: https://doi.org/10.1111/j.1399-0004.2007.00768.x]

  24. Taj-Eldin, S., Al-Jawad, J. Cortical hyperostosis: infantile and juvenile manifestations in a boy. Arch. Dis. Child. 46: 565-566, 1971. [PubMed: 4935623] [Full Text: https://doi.org/10.1136/adc.46.248.565]

  25. Tampas, J. P., Van Buskirk, F. W., Peterson, O. S., Soule, A. B. Infantile cortical hyperostosis. JAMA 175: 491-493, 1961. [PubMed: 13775121] [Full Text: https://doi.org/10.1001/jama.1961.63040060003014]

  26. Van Buskirk, F. W., Tampas, J. P., Peterson, O. S., Jr. Infantile cortical hyperostosis: an inquiry into its familial aspects. Am. J. Roentgen. Radium Ther. Nucl. Med. 85: 613-632, 1961. [PubMed: 13779881]


Contributors:
Nara Sobreira - updated : 6/17/2009
Cassandra L. Kniffin - updated : 8/29/2007
Marla J. F. O'Neill - updated : 5/20/2005

Creation Date:
Victor A. McKusick : 6/4/1986

Edit History:
carol : 01/03/2024
carol : 01/02/2024
alopez : 02/15/2022
carol : 01/28/2020
carol : 01/21/2015
carol : 4/5/2012
carol : 6/18/2009
terry : 6/17/2009
terry : 6/3/2009
terry : 1/8/2009
wwang : 9/10/2007
ckniffin : 8/29/2007
carol : 6/23/2005
carol : 6/23/2005
carol : 5/25/2005
wwang : 5/23/2005
terry : 5/20/2005
alopez : 3/17/2004
alopez : 4/8/1999
alopez : 7/9/1997
terry : 3/26/1996
mark : 1/16/1996
terry : 1/11/1996
carol : 3/7/1995
davew : 6/9/1994
terry : 5/13/1994
mimadm : 4/9/1994
warfield : 4/6/1994
carol : 10/26/1993